TENAX THERAPEUTICS, INC.
TENX나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
5건
최근 2026.10.21
90일 내부자 순매수
+44억 8,058만원
순매수
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 12건
- US미국임원·주요주주 소유중요도 높음2026.10.214 · Statement of changes in beneficial ownership
TENAX THERAPEUTICS, INC.TENX
Form 4 · 2026.10.21
- US미국대량보유(5%)중요도 낮음2026.10.15정정SCHEDULE 13G/A · Beneficial ownership report (13G)
TENAX THERAPEUTICS, INC.TENX
SCHEDULE 13G/A · 2026.10.15
- US미국대량보유(5%)중요도 낮음2026.10.13정정SCHEDULE 13G/A · Beneficial ownership report (13G)
TENAX THERAPEUTICS, INC.TENX
SCHEDULE 13G/A · 2026.10.13
- US미국대량보유(5%)중요도 낮음2026.10.09정정SCHEDULE 13G/A · Beneficial ownership report (13G)
TENAX THERAPEUTICS, INC.TENX
SCHEDULE 13G/A · 2026.10.09
- US미국주요사항·수시공시중요도 낮음2026.10.098-K · Current report (Items 8.01, 9.01)
TENAX THERAPEUTICS, INC.TENX
8-K · 2026.10.09 05:15 KST
- US미국임원·주요주주 소유중요도 보통2026.09.174 · Statement of changes in beneficial ownership
TENAX THERAPEUTICS, INC.TENX
Form 4 · 2026.09.17
- US미국임원·주요주주 소유중요도 낮음2026.09.154 · Statement of changes in beneficial ownership
TENAX THERAPEUTICS, INC.TENX
Form 4 · 2026.09.15
- US미국임원·주요주주 소유중요도 낮음2026.09.154 · Statement of changes in beneficial ownership
TENAX THERAPEUTICS, INC.TENX
Form 4 · 2026.09.15
- US미국주요사항·수시공시중요도 낮음2026.09.098-K · Current report (Items 7.01, 9.01)
TENAX THERAPEUTICS, INC.TENX
8-K · 2026.09.09 21:00 KST
- US미국대량보유(5%)중요도 낮음2026.09.08정정SCHEDULE 13G/A · Beneficial ownership report (13G)
TENAX THERAPEUTICS, INC.TENX
SCHEDULE 13G/A · 2026.09.08